Invion Limited

ASX (AUD): Invion Limited (IVX)

Last Price

0.26

Today's Change

0.00 (0.00%)

Day's Change

0.26 - 0.26

Trading Volume

1,807

Overview

Market Cap

18 Million

Shares Outstanding

69 Million

Avg Volume

75,693

Avg Price (50 Days)

0.23

Avg Price (200 Days)

0.37

PE Ratio

-2.89

EPS

-0.09

Earnings Announcement

26-Feb-2025

Previous Close

0.26

Open

0.26

Day's Range

0.26 - 0.26

Year Range

0.105 - 0.7

Trading Volume

1,807

Price Change Highlight

1 Day Change

0.00%

5 Day Change

-8.77%

1 Month Change

23.81%

3 Month Change

8566.67%

6 Month Change

5100.00%

Ytd Change

5100.00%

1 Year Change

4233.33%

3 Year Change

1268.42%

5 Year Change

1900.00%

10 Year Change

600.51%

Max Change

-14.31%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment